|
US-EU AI Administrative Agreement
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
NCI
|
In January, 2023, the US and EU signed an Administrative Agreement to collaborate on research using AI, computing and privacy-related technologies. NCI is engaged under the “Health and Medicine” focus group. This group will address AI applications for using federated MR imaging and associated clinical metadata in breast and prostate cancer to diagnose and understand the biology of these diseases. The project will seek to incorporate data types from several sources and different populations including two sites in Africa, and include “orphan datasets” from the US and Europe.
|
|
US-EU AI4Public Good Health
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
NCI
|
WH task force
|
|
US-EU Bilateral Health Focus Group Meeting
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NCI
|
address new challenges around cancer, global health threats and strengthening the global health infrastructure
|
|
US-Israel White House-HHS Taskforce on Pandemic Preparedness and Innovation
|
Committee, Work group, Advisory group, or Task Force
|
ASPR, CDC
|
NIBIB
|
A partnership between the US and Israel on critical and emerging technologies to bring the cooperation between the countries to new heights including innovations for pandemic preparedness.
|
|
US-Japan Cooperative Medical Science Program (CMSP)
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
NCI, NIAID
|
The National Cancer Institute (NCI) and the National Institute of Allergy and Infectious Diseases (NIAID) participate in the 58-year-old US-Japan Cooperative Medical Science Program (CMSP). The Program sponsors international meetings, workshops, and conferences on health issues of concern to the countries of the Pacific Rim. These conferences are designed to draw attention and to serve as a clearinghouse of scientific and public health information, and to identify areas of research that need additional emphasis or support. The U.S.-Japan CMSP fosters exchange of scientists between the United States and Japan, which enriches the training of young scientists and leads to important collaborative research. The Program also seeks research collaborations in Southeast Asian countries on health topics of mutual interest. Funding for the U.S.-Japan CMSP is provided by each country. Planning began in FY2023 for the 2024 International Conference.
|
|
USAID Malaria Vaccine Development Program Scientific Consultants Group
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
NIAID
|
None
|
|
USCDI + Cancer
|
Committee, Work group, Advisory group, or Task Force
|
ONC
|
NCI
|
Group developing standard data elements to facilitate clinical trial matching, immune-related adverse event reporting, and cancer registry reporting
|
|
USG pandemic preparedness portfolio sharing group
|
Committee, Work group, Advisory group, or Task Force
|
ASPR, BARDA
|
ARPA-H, NIAID
|
Working group meetings bi-monthly to share portfolios and activities on vaccine and monoclonal antibody development for viruses with pandemic preparedness.
|
|
Using Real-time Prescription and Insurance Claims Data to Support the HIV Care Continuum
|
Research Initiative
|
CDC
|
NIMH
|
The Centers for Disease Control and Prevention (CDC) and the National Institute of Mental Health (NIMH) have established a cooperative agreement titled “Using Real-time Prescription and Insurance Claims Data to Support the HIV Care Continuum (CDC RFA-PS-19-003).” The purpose of the cooperative agreement is to develop, implement, and evaluate a “insurance-based data-to-care (D2C)” model. The insurance-based D2C model will start with Medicaid claims (diagnosis and procedure) to identify persons with diagnosed HIV, and then use real-time Medicaid claims data to determine whether these individuals have current antiretroviral (ARV) prescriptions. Persons with HIV who show lapsed ARV medications will receive a set of escalating adherence, retention, and re-linkage interventions. The research study will test the effectiveness of the approach (on viral suppression) as well as the cost-effectiveness of the approach.
|
|
VA Dementia Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
NIA
|
Veteran's Administration runs a Steering Committee for dementia-related issues.
|